Each mL contains albendazole 40 mg.
Pharmacology: Pharmacodynamics: Albendazole exhibits vermicidal, ovicidal and larvicidal activity. Alben-Kid probably exerts its anthelmintic effect by blocking glucose uptake by the susceptible helminths, thereby depleting their energy level until it becomes inadequate for survival. Albendazole initially immobilizes, then kills the susceptible helminths.
Treatment of threadworm, roundworm, whipworm, hookworm, pinworm, tapeworm and mixed helminthic infestations. Hydatid disease and neurocysticercosis. Albendazole is also indicated in the treatment of giardiasis in children >2 years.
Adults and Children >2 Years: Hookworm, Roundworm and Whipworm Infestations 10 mL as single-dose. Threadworm and Tapeworm Infestations 10 mL once daily for 3 consecutive days.
Giardiasis: Adults: 400 mg once daily for 5 days. Children 1-2 Years: 200 mg once daily for 5 days. If the patient is not cured after 3 weeks, a 2nd course is recommended.
Parenchymal Neurocysticercosis: Patients Weighing 60 kg: 400 mg twice daily with meals for 8-30 days. <60 kg: 15 mg/kg/day in 2 divided doses. Maximum Dose: 800 mg/day.
Administration: No special procedures eg, fasting or purging are required.
Symptoms: In animals, symptoms were demonstrated in a dose-response relationship and included diarrhoea, vomiting, tachycardia and respiratory distress.
An overdosage has been reported with albendazole in a patient who took at least 16 g over 12 hrs. No untoward effect was reported.
Treatment: In case of overdosage, symptomatic therapy (eg, gastric lavage and activated charcoal) and general supportive measures are recommended.
Use in pregnancy: There are no adequate and well-controlled studies of albendazole in pregnant women. Alben-Kid should be used during pregnancy only if potential benefit justifies the potential risk to the fetus.
Use in lactation: It is known whether albendazole is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when albendazole is administered to nursing women.
Use in pregnancy: There are no adequate and well-controlled studies of albendazole in pregnant women. Alben-Kid should be used during pregnancy only if potential benefit justifies the potential risk to the fetus.
Use in lactation: It is known whether albendazole is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when albendazole is administered to nursing women.
Occasional gastrointestinal disturbances, dizziness and headache have been reported. With high doses, rarely reversible alopecia and rash have been reported. Fever has been reported during the 1st few days of treatment.
No interactions involving albendazole either pharmacodynamic or pharmacokinetic have been reported.
Store in a cool, dry place. Protect from light.
P02CA03 - albendazole ; Belongs to the class of benzimidazole derivative agents. Used as antinematodal.
Oral susp 40 mg/mL x 10 mL.
Sign Out
